Home/Filings/4/0001209191-21-017546
4//SEC Filing

Huang Dennis Karl 4

Accession 0001209191-21-017546

CIK 0001515673other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 8:39 PM ET

Size

11.9 KB

Accession

0001209191-21-017546

Insider Transaction Report

Form 4
Period: 2021-03-01
Transactions
  • Award

    Common Stock

    2021-03-01+4,63644,835 total
  • Sale

    Common Stock

    2021-03-01$138.18/sh4,255$587,95640,761 total
  • Award

    Common Stock

    2021-03-01+5,50040,199 total
  • Award

    Stock Option (Right to Buy)

    2021-03-01+11,00011,000 total
    Exercise: $142.47Exp: 2031-03-01Common Stock (11,000 underlying)
Footnotes (7)
  • [F1]Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.
  • [F2]Represents 1,530 shares of common stock and 3,106 RSUs into which previously granted performance stock units were converted on March 1, 2021 upon certification of the performance metric. The RSUs will fully vest on March 1, 2022.
  • [F3]Represents shares sold to pay required tax withholdings due to the vesting of RSUs.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.17 to $138.19 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F5]Includes 181 shares acquired under the Company's 2014 Employee Stock Purchase Plan on October 31, 2020.
  • [F6]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
  • [F7]On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.

Issuer

Ultragenyx Pharmaceutical Inc.

CIK 0001515673

Entity typeother

Related Parties

1
  • filerCIK 0001641217

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 8:39 PM ET
Size
11.9 KB